Subway Microbiome Study Revised

Researchers tone down their highly publicized study that reported the presence of deadly pathogens on New York City subways.

Written byAmanda B. Keener
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

PIXABAY, SOFUEGOPRODUCTIONS

In the wake of media reports suggesting the New York City subways are littered with anthrax and the bacteria that cause bubonic plague, a letter published in Cell Systems last week (July 29) by the authors of a February study that cataloged the microbiome of the subway system made it clear that this is not the case.

“There is no strong evidence to suggest these organisms are in fact present, and no evidence of pathogenicity,” the authors wrote in their correspondence.

The letter, along with edits made to the original study, was in response to another letter, penned by officials at the US Centers for Disease Control and Prevention and the New York City Department of Health and Mental Hygiene, who challenged the authors’ interpretation ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies